These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27453413)

  • 1. Prognostic role of s-phase kinase-associated protein 2 in breast cancer: A meta-analysis.
    Shi Y; Li N; Ren H; Guo X; Li Q; Ma S; Wang D
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E153-7. PubMed ID: 27453413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic implications of SIRTs expression in breast cancer: a systematic review and meta-analysis.
    Zhang H; Ma C; Peng M; Lv X; Xie X; Huang R
    Discov Oncol; 2022 Aug; 13(1):69. PubMed ID: 35927590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
    Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
    Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of skp2 expression in primary breast cancer.
    Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
    Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.
    Wang Y; Zhang Y; Pan C; Ma F; Zhang S
    PLoS One; 2015; 10(2):e0118647. PubMed ID: 25706383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
    Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
    Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
    Zhang Z; Luo G; Tang H; Cheng C; Wang P
    PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
    Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of F-box members in breast cancer: an online database analysis and literature review.
    Wang X; Zhang T; Zhang S; Shan J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30341246
    [No Abstract]   [Full Text] [Related]  

  • 11. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
    Xu TP; Shen H; Liu LX; Shu YQ
    Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
    Lin SC; Gan ZH; Yao Y; Min da L
    PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis.
    Zhang S; Cheng T
    Ann Med; 2024 Dec; 56(1):2337729. PubMed ID: 38569199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of Skp2 and p27 in human breast cancer.
    Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
    Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
    Tan G; Chu C; Gui X; Li J; Chen Q
    Medicine (Baltimore); 2018 Mar; 97(13):e0197. PubMed ID: 29595655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis.
    Li C; Yuan Q; Deng T; Xu G; Hou J; Zheng L; Wu G
    Breast Cancer; 2023 Nov; 30(6):965-975. PubMed ID: 37470943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
    Fujita T; Liu W; Doihara H; Date H; Wan Y
    Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis.
    Zhang DP; Li XW; Lang JH
    Asian Pac J Cancer Prev; 2015; 16(14):5625-33. PubMed ID: 26320427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.